Stay updated on MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial page.

Latest updates to the MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; no changes to study data, criteria, or listed locations are evident.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check19 days agoChange DetectedThe page shows a minor metadata revision from v3.4.0 to v3.4.1; no user-facing content or functionality appears to be altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision: v3.3.4 replaces the previous v3.3.3 label on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedLocations section updated to consolidate all study sites under a single 'Locations' heading, adding California, Connecticut, Florida, Illinois, Maryland, New York, Ohio, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, and Quebec. Individual state location headings were removed in favor of a unified Locations list.SummaryDifference1%

- Check91 days agoChange DetectedThe page now displays revision label v3.3.2 and the previous v3.2.0 label is removed.SummaryDifference0.0%

- Check99 days agoChange DetectedThe notice about government funding and data currency was removed from the page. No new content was added.SummaryDifference0.3%

Stay in the know with updates to MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial page.